참고문헌
- Bae J, Won M, Kim DY, et al (2012). Identification of differentially expressed microRNAs in endometrial cancer cells after progesterone treatment. Int J Gynecol Cancer, 22, 561-5. https://doi.org/10.1097/IGC.0b013e31824927db
- Banno K, Yanokura M, Kisu I, et al (2013). MicroRNAs in endometrial cancer. Int J Clin Oncol, 18, 186-92. https://doi.org/10.1007/s10147-013-0526-9
- Baskerville S, Bartel DP (2005). Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA, 11, 241-7. https://doi.org/10.1261/rna.7240905
- Bell DW (2014). Novel genetic targets in endometrial cancer. Expert Opin Ther Targets, 18, 725-30. https://doi.org/10.1517/14728222.2014.909414
- Chekmenev DS, Haid C, Kel AE (2005). P-Match: transcription factor binding site search by combining patterns and weight matrices. Nucleic Acids Res, 33, 432-7. https://doi.org/10.1093/nar/gki441
- Cheung LWT (2012). High Frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTENprotein stability. Cancer Discov, 2, 750-1. https://doi.org/10.1158/2159-8290.CD-12-0280
- Choi CH, Park YA, Choi JJ, et al (2012). Angiotensin II type I receptor and miR-155 in endometrial cancers: Synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells. Gynecol Oncol, 126, 124-31. https://doi.org/10.1016/j.ygyno.2012.04.020
- Cohn DE, Fabbri M, Valeri N, et al (2010). Comprehensive miRNA profiling of surgically staged endometrial cancer. Am J Obstet Gynecol, 202, 656.
- Dong PX, Kaneuchi M, Watari H, Sudo S, Sakuragi N (2014). MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines. Mol Carcinog, 53, 349-59. https://doi.org/10.1002/mc.21983
- Fujita PA, Rhead B, Zweig AS, et al (2011). The UCSC Genome Browser database: update 2011. Nucleic Acids Res, 39, 876-82. https://doi.org/10.1093/nar/gkq963
- Hobert O (2008). Gene regulation by transcription factors and microRNAs. Science, 319, 1785-6. https://doi.org/10.1126/science.1151651
- Hsu SD, Tseng YT, Shrestha S, et al (2014). miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res, 42, 78-85.
- Janiec-Jankowska A, Konopka B, Goluda C, Najmola U (2010). TP53 mutations in endometrial cancers relation to PTEN gene defects. Int J Gynecol Cancer, 20, 196-202. https://doi.org/10.1111/IGC.0b013e3181c83675
- Jiang QH, Wang YD, Hao YY, et al (2009). miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res, 37, 98-104.
- Kawaguchi M, Banno K, Yanokura M, et al (2009). Analysis of candidate target genes for mononucleotide repeat mutation in microsatellite instability-high (MSI-H) endometrial cancer. Int J Oncol, 35, 977-82.
- Kozomara A, Griffiths-Jones S (2011). miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res, 39, 152-7.
- Krakstad C, Birkeland E, Seidel D, et al (2012). High-throughput mutation profiling of pri-mary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to Be Frequently Mutated. PLoS One, 7, 52795. https://doi.org/10.1371/journal.pone.0052795
- Li B, Chen H, Shang LX, Gao W (2014). MicroRNA-543 suppresses endometrial cancer on-cogenicity via targeting FAK and TWIST1 expression. Arch Gynecol Obstet, 290, 533-41. https://doi.org/10.1007/s00404-014-3219-3
- Li BL, Lu C, Lu W, et al (2013). miR-130b is an EMTrelated microRNA that targets DIC-ER1 for aggression in endometrial cancer. Med Oncol, 30, 484. https://doi.org/10.1007/s12032-013-0484-0
- Li BL, Lu W, Lu C, et al (2013). CpG island hypermethylationassociated silencing of microRNAs promotes human endometrial cancer. Cancer Cell Int, 13, 44. https://doi.org/10.1186/1475-2867-13-44
- Li J, Xu ZW, Wang KH, et al (2013). Networks of microRNAs and genes in retinoblastomas. Asian Pac J Cancer Prev, 14, 6631-6. https://doi.org/10.7314/APJCP.2013.14.11.6631
- Lv SQ, Kim YH, Giulio F, et al (2012). Genetic Alterations in MicroRNAs in medulloblastomas. Brain Pathol, 22, 230-9. https://doi.org/10.1111/j.1750-3639.2011.00523.x
- Mackay HJ, Eisenhauer EA, Kamel-Reid S, et al (2014). Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer. Cancer, 120, 603-10. https://doi.org/10.1002/cncr.28414
- Myatt SS, Wang J, Monteiro LJ, et al (2010). Definition of microRNAs that repress expres-sion of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res, 70, 367-77. https://doi.org/10.1158/0008-5472.CAN-09-1891
- Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P, Hatzigeorgiou AG (2009). The database of experimentally supported targets: a functional update of TarBase. Nucleic Acids Res, 37, 155-8. https://doi.org/10.1093/nar/gkn809
- Price JC, Pollock LM, Rudd ML, et al (2013). Sequencing of candidate chromosome insta-bility genes in endometrial cancers cancers reveals somatic mutations in ESCO1, CHTF18, and MRE11A. PLoS One, 8, 63313. https://doi.org/10.1371/journal.pone.0063313
- Qin XY, Yan L, Zhao XB, Li CY, Fu YB (2012). microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer. Oncol Lett, 4, 1290-6.
- Ramon LA, Braza-Boils A, Gilabert J, et al (2012). microRNAs related to angiogenesis are dysregulated in endometrioid endometrial cancer. Hum Reprod, 27, 3036-45. https://doi.org/10.1093/humrep/des292
- Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A (2004). Identification of mammalian microRNA host genes and transcription units. Genome Res, 14, 1902-10. https://doi.org/10.1101/gr.2722704
- Samulak D, Grosman-Dziewiszek P, Michalska MM, et al (2014). Evaluation of expression of the PTEN gene, oestrogen and progesterone receptors as diagnostic and predictive factors in endometrial cancer. Pathol Oncol Res, 20, 191-6. https://doi.org/10.1007/s12253-013-9684-3
- Shang C, Lu YM, Meng LR (2012). MicroRNA-125b downregulation mediates endometrial cancer invasion by targeting ERBB2. Med Sci Monit, 18, 149-55.
- Thanapprapasr D, Thanapprapasr K (2013). Molecular therapy as a future strategy in endometrial cancer. Asian Pac J Cancer Prev, 14, 3419-23. https://doi.org/10.7314/APJCP.2013.14.6.3419
- Torres A, Torres K, Wdowiak P, Paszkowski T, Maciejewski R (2013). Selection and validation of endogenous controls for microRNA expression studies in endometrioid endometrial cancer tissues. Gynecol Oncol, 130, 588-94. https://doi.org/10.1016/j.ygyno.2013.06.026
- Tran DH, Satou K, Ho TB, Pham TH (2010). Computational discovery of miR-TF regulatory modules in human genome. Bioinformation, 4, 371-7. https://doi.org/10.6026/97320630004371
- Tsuruta T, Kozaki K, Uesugi A, et al (2011). miR-152 Is a tumor suppressor microRNA That is silenced by DNA hypermethylation in endometrial cancer. Cancer Res, 71, 6450-62. https://doi.org/10.1158/0008-5472.CAN-11-0364
- Wang HY, Shen J, Jiang CP, Liu BR (2014). How to explain the contradiction of microRNA 200c expression and survival in solid tumors?: a meta-analysis. Asian Pac J Cancer Prev, 15, 3687-90. https://doi.org/10.7314/APJCP.2014.15.8.3687
- Wang J, Lu M, Qiu CX, Cui QH (2010). TransmiR: a transcription factor-microRNA regulation database. Nucleic Acids Res, 38, 119-22.
- Wang N, Xu ZW, Wang KH, Zhu MH, Li Y (2014). Construction and analysis of regulatory genetic networks in cervical cancer based on involved microRNAs, target genes, transcription factors and host genes. Oncol Lett, 7, 1279-83.
- Wu D, Huang HJ, He CN, Wang KY (2013). MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR). Int J Gynecol Cancer, 23, 1191-7. https://doi.org/10.1097/IGC.0b013e31829ea779
- Xiao FF, Zuo ZX, Cai GS, et al (2009). miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res, 37, 105-10.
- Xu YY, Wu HJ, Ma HD, et al (2013). MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1. Febs J, 280, 3768-79. https://doi.org/10.1111/febs.12365
- Ye WW, Xue JS, Zhang Q, et al (2014). MiR-449a functions as a tumor suppressor in endometrial cancer by targeting CDC25A. Oncol Rep, 32, 1193-9.
- Zhang GY, Hou XX, Li Y, Zhao M (2014). MiR-205 inhibits cell apoptosis by targeting phosphatase and tensin homolog deleted on chromosome ten in endometrial cancer ishikawa cells. BMC Cancer, 14, 440. https://doi.org/10.1186/1471-2407-14-440